Quarterly ResultApr 29, 2026, 04:32 PM
HCA Q1 Revenue +4.3% to $19.1B; EPS $7.15; Operating Cash +22%
AI Summary
HCA Healthcare, Inc. reported Q1 2026 revenues of $19.11 billion, a 4.3% increase year-over-year, with diluted earnings per share rising 10.8% to $7.15. Net income attributable to HCA Healthcare, Inc. grew slightly to $1.62 billion. The company generated $2.01 billion in net cash from operating activities, up 22% from the prior year, and repurchased $1.57 billion of common stock. However, estimated uncompensated care costs increased by 18.7% to $1.25 billion.
Key Highlights
- Q1 2026 Revenues increased 4.3% to $19.11 billion from $18.32 billion in Q1 2025.
- Diluted EPS rose 10.8% to $7.15 in Q1 2026, compared to $6.45 in Q1 2025.
- Net income attributable to HCA Healthcare, Inc. was $1.62 billion, up from $1.61 billion.
- Net cash provided by operating activities increased 22% to $2.01 billion in Q1 2026.
- Company repurchased $1.57 billion of common stock (3.157 million shares) in Q1 2026.
- National Group Adjusted segment EBITDA increased 11.1% to $1.26 billion.
- Estimated cost of total uncompensated care increased 18.7% to $1.25 billion.
- Effective tax rate decreased to 18.8% in Q1 2026 from 21.6% in Q1 2025.
Price Impact
More from HCA